Novartis (NVS) Tops Q3 EPS by 4c

Novartis (NYSE: NVS) reported Q3 EPS of $1.29, $0.04 better than the analyst estimate of $1.25. Revenue for the quarter came in at $12.41 billion versus the consensus estimate of $12.25 billion.

2017 Group outlook re-confirmed; net sales expected to be broadly in line with prior year (cc), core operating income expected to be broadly in line or decline low single digit (cc).

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• MetaVia Inc. (MTVA) Tops Q2 EPS by 73c
• Under Armour Inc (UAA) Tops Q1 EPS by 3c